Â鶹´«Ã½Ó³»­

June 9, 2026

Clinicians looking for a comprehensive, clinically focused program to keep them at the forefront of diagnosing and managing complex autoimmune neurological disorders won’t want to miss the 2026 Â鶹´«Ã½Ó³»­ Autoimmune Neurology Conference August 7–8. Presented in a hybrid format with the option to attend in person in Houston, TX, or online, the conference combines flexibility with high-impact learning, ensuring attendees can access sessions in a way that best suits their schedules.

Comprehensive updates and deep dives

Balancing a mix of keynotes, clinical updates, and case-based sessions with a strong emphasis on translating pathophysiology into treatment, the conference program will offer comprehensive state-of-the-field updates while diving deep into both common and rare conditions such as myasthenia gravis, neuromyelitis optica spectrum disorder, autoimmune encephalitis, inflammatory myopathies, and paraneoplastic syndromes. Forward-thinking sessions will also explore the latest developments in genetics and disease mechanisms, giving clinicians valuable perspectives on emerging trends and future directions in autoimmune neurology.

The sessions are curated to ensure that clinicians not only grasp the underlying mechanisms of autoimmune disorders but also gain actionable insights for improving patient outcomes. Interactive poster sessions further enhance the experience, allowing attendees to connect with peers and thought leaders across diverse practice settings.

Keynote presentations:

The Glymphatic System
Jeffrey Iliff, PhD, is a world-renowned neuroscientist and professor of psychiatry and behavioral sciences and neurology at the University of Washington School of Medicine, as well as associate director for research at the VA Puget Sound Health Care System. He is internationally recognized for his foundational role in discovering and naming the glymphatic system. His work is considered highly influential, as the discovery of this brain-wide waste clearance network was cited by Science  as one of the Top 10 Breakthroughs of 2013. 

Paraneoplastic Neurological Syndromes: Key Lessons from Four Decades of Research
Francesc R. Graus, MD, PhD, is an internationally recognized neurologist and neuroimmunologist and an Emeritus Investigator at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Hospital Clínic of Barcelona. He is a pioneer in the field of paraneoplastic neurological syndromes and autoimmune encephalitis, and arguably the most prominent figure in this field globally. He is widely considered a foundational “master" of autoimmune neurology, having led the international expert panels that established the standard diagnostic criteria used by clinicians worldwide.  

Early registration savings end June 18

Be sure to secure the deepest discounts by registering before June 18. And if joining us in person in Houston, be sure and book your hotel by July 16.